Acadian Asset Management LLC Athenex, Inc. Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $0.21 $18,259 - $31,954	152,163 Added 40.98%	523,452 $75,000
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $59,565 - $275,492	248,191 Added 201.62%	371,289 $99,000
Q2 2022 Aug 09, 2022	BUY	$0.41 - $0.91 $50,470 - $112,019	123,098 New	123,098 $51,000
Q1 2022 May 12, 2022	SELL	$0.79 - $1.59 $88,846 - $178,817	-112,464 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$1.36 - $2.94 $152,951 - $330,644	112,464 New	112,464 $152,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.